Lundbeck
HLUN-B.CO
#2700
Rank
HK$50.26 B
Marketcap
HK$52.96
Share price
0.80%
Change (1 day)
15.35%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2025 (TTM): HK$4.78

According to Lundbeck's latest financial reports the company's current EPS (TTM) is HK$4.79. In 2024 the company made an earnings per share (EPS) of HK$3.46 an increase over its 2023 EPS that were of HK$2.67.

EPS history for Lundbeck from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)HK$4.7838.19%
2024HK$3.4629.29%
2023HK$2.6723.09%
2022HK$2.1737.26%
2021HK$1.58-84.61%
2020HK$10.28-24.61%
2019HK$13.64-42.06%
2018HK$23.5440.7%
2017HK$16.73146.26%
2016HK$6.79-120.48%
2015-HK$33.163231.32%
2014-HK$1.00-115.78%
2013HK$6.31-23.36%
2012HK$8.23-48.01%
2011HK$15.83-9.68%
2010HK$17.5313.72%
2009HK$15.4124.32%
2008HK$12.40-6.05%
2007HK$13.2081.77%
2006HK$7.26-16.76%
2005HK$8.72-17.58%
2004HK$10.58